Three early-career scientists who recently completed their PhDs at Northwestern have been named Chicago Biomedical Consortium ...

The clinical research landscape is rapidly transforming. Instead of viewing patients as subjects, sponsors now use the patients’ input to help reduce the burden they face during trials. This ...

Through multiomics—combined genomics, transcriptomics, proteomics, digital pathology, and other technologies yet to fully unfold—we can now obtain a complete dynamic vision of cancer,” argue the ...

Over the past several years, pharmaceutical companies have been steadily integrating artificial intelligence (AI) into many aspects of clinical development. Today, AI’s impact is being felt from the ...

Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis of drugs included in this ...

Wave Life Sciences Ltd. announced the completion of dosing in the first two cohorts of the INLIGHT trial for the obesity treatment WVE-007, with clinical data expected in the second half of 2025. The ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

The speed of medicine has changed. Healthcare professionals are no longer waiting for conferences or clinical guidelines to make key decisions. In fast-paced clinical settings, physicians are actively ...